Insulin Glargine v Rosiglitazone as add-on Therapy in Patients Failing Sulfonylurea and Metformin Combination Therapy
Status:
Completed
Trial end date:
2002-06-01
Target enrollment:
Participant gender:
Summary
To compare the glycemic control, as measured by HbA1C, between insulin glargine and
rosiglitazone add-on therapies in patients who fail oral combination of a sulfonylurea and
metformin